Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cited by (1,003)

Items 501–600 of 1,003

1. Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells
   Jeffrey Arrindell, Perla Abou Atmeh, Laurie Jayet, Youssouf Sérémé, Jean‐Louis Mège, Benoît Desnues · 2022 · iScience
2. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications
   Prakash Patil, Praveenkumar K. Shetty, Nithin Kuriakose, Pavan Gollapalli, Sukanya Shetty, Roopa Rani Bhandary, Jamboor K. Vishwanatha, Sudeep Darbhe Ghate · 2021 · International Journal of Molecular Sciences
3. USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
   Jinqiu Zhao, Jie Bai, Fengling Peng, Chan Qiu, Yongguo Li, Li Zhong · 2023 · Cell Death and Disease
4. Olfactory immune response to SARS-CoV-2
   Sebastian A. Wellford, E. Ashley Moseman · 2023 · Cellular and Molecular Immunology
5. Significance of Artificial Intelligence in the Study of Virus–Host Cell Interactions
   James Elste, Akash Saini, Rafael Mejía-Alvarez, Armando Mejía, César Millán‐Pacheco, Michelle Anne Swanson-Mungerson, Vaibhav Tiwari · 2024 · Biomolecules
6. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
   Periklis Katopodis, Rachel Kerslake, Julie Davies, Harpal Singh Randeva, Kamaljit Kaur Chatha, Marcia Hall, Demetrios A. Spandidos, Vladimir Anikin, Andreas Polychronis, Jan Lukas Robertus et al. · 2021 · International Journal of Molecular Medicine
7. Neurological update: COVID-19
   Alexander Liang Ren, Richard John Digby, Edward Needham · 2021 · Journal of Neurology
8. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists
   Methus Klaewkla, Thanapon Charoenwongpaiboon, Panupong Mahalapbutr · 2021 · Journal of Molecular Liquids
9. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
   Mark Howell, Ryan J. Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Cancers
10. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
    Adam Pickard, Ben C. Calverley, Joan Chang, Richa Garva, Sara Gago, Yinhui Lu, Karl E. Kadler · 2021 · PLoS Pathogens
11. ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
    Bushra Memon, Essam Mohamed Abdelalim · 2021 · Acta Physiologica
12. Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19
    Boris Tizenberg, Lisa A. Brenner, Christopher A. Lowry, Olaoluwa O. Okusaga, David R. Benavides, Andrew J. Hoisington, Michael E. Benros, John W. Stiller, Ronald C. Kessler, Teodor T. Postolache · 2021 · Current Psychiatry Reports
13. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
    Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh · 2021 · Molecular Biomedicine
14. Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry
    Puspangana Singh, Shreya Mukherji, Swarnendu Basak, Markus Hoffmann, Dibyendu Kumar Das · 2022 · Cell Reports
15. Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner
    Meng Chen, Menghang Wang, Xue-Gang Shen, Hao Liu, Yuyuan Zhang, Jinmei Peng, Fandan Meng, Tong-Yun Wang, Yuanzhe Bai, Mingxia Sun et al. · 2022 · Journal of Virology
16. The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice
    Xiaoling Cao, Vi Nguyen, Joseph C. Tsai, Chao Gao, Yan Tian, Yuping Zhang, Wayne E. Carver, Hippokratis Kiaris, Taixing Cui, Wenbin Tan · 2023 · Molecular Metabolism
17. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease
    Jiang Chen, Junsheng Chen, Zhifeng Lei, Fengning Zhang, Linghui Zeng, Ximei Wu, Song Li, Jun Tan · 2023 · Translational Psychiatry
18. Neuroimmune pathophysiology of long COVID
    Janna K. Moen, Christopher A. Baker, Akiko Iwasaki · 2025 · Psychiatry and Clinical Neurosciences
19. Complications and Pathophysiology of COVID-19 in the Nervous System
    Haiyang Yu, Tong Sun, Juan Feng · 2020 · Frontiers in Neurology
20. Mucin signature as a potential tool to predict susceptibility to COVID‐19
    Mukulika Bose, Bhaskar Mitra, Pinku Mukherjee · 2020 · Physiological Reports
21. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS‐CoV‐2
    Yanchao Li, Yan Zhang, Bai‐Hong Tan · 2021 · Journal of Medical Virology
22. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease
    George D. Vavougios, Christiane M. Nday, Sigliti‐Henrietta Pelidou, Konstantinos I. Gourgoulianis, George I. Stamoulis, Triantafyllos K. Doskas, Sotirios G. Zarogiannis · 2021 · Brain Behavior & Immunity - Health
23. The Spike of SARS-CoV-2: Uniqueness and Applications
    Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flávia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid Jamaan Alzahrani, Aristóteles Goés‐Neto et al. · 2021 · Frontiers in Immunology
24. Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection
    Longping V. Tse, Rita M. Meganck, Kenza C. Araba, Boyd L. Yount, Kendall M. Shaffer, Yixuan Jacob Hou, Jennifer E. Munt, Lily E. Adams, Jason A. Wykoff, Jeremy M. Morowitz et al. · 2022 · Proceedings of the National Academy of Sciences
25. Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
    Erika Cecon, Daniela Fernandois, Nicolas Renault, Caio Fernando Ferreira Coêlho, Jan Wenzel, Corentin Bedart, Charlotte Izabelle, Sarah Gallet, Sophie Le Poder, Bernard Klonjkowski et al. · 2022 · Cellular and Molecular Life Sciences
26. Ganoderma lucidum polysaccharides ameliorate lipopolysaccharide-induced acute pneumonia via inhibiting NRP1-mediated inflammation
    Xue-Lian Zhang, Daoshun Wu, Yu Tian, Xiang-Dong Chen, Jin Lan, Fei-Long Wei, Ye Li, Yun Luo, Xiao-Bo Sun · 2022 · Pharmaceutical Biology
27. SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry
    Olga Viktorovna Matveeva, Yury D. Nechipurenko, Denis Lagutkin, Yegor E. Yegorov, Julia G. Kzhyshkowska · 2022 · Frontiers in Immunology
28. mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation
    Jacques Demongeot A, Cécile Fougère · 2022 · Vaccines
29. Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry
    Qiyu Tong, Geng Liu, Xiongbo Sang, Xin-Yue Zhu, Xiao-Li Fu, C. Dou, Yue Jian, Jia-Ni Zhang, Sailan Zou, Gui-xiang Zhang et al. · 2023 · PLoS Pathogens
30. Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors
    Hamidreza Zalpoor, Hooriyeh Shapourian, Abdullatif Akbari, Shaghayegh Shahveh, Leila Haghshenas · 2022 · Human Cell
31. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach
    Muhammad Zaheer, Nouman Safdar Ali, Hasnain Javed, Rimsha Munir, Nazia Jamil · 2023 · Journal of Infection and Public Health
32. COVID-19 in the Initiation and Progression of Atherosclerosis
    Vignesh Chidambaram, Amudha Kumar, Murrium I. Sadaf, Emily Lu, Subhi Jamal Alaref, Tushar Tarun, Panagis Galiatsatos, Martha Gulati, Roger Scott Blumenthal, Thorsten Martin Leucker et al. · 2024 · JACC Advances
33. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
    Loukia Yiangou, Richard P. Davis, Christine L. Mummery · 2020 · Stem Cell Reports
34. Charged amino acids may promote coronavirus SARS-CoV-2 fusion with the host cell
    Piotr H. Pawłowski · 2021 · AIMS Biophysics
35. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
    Amarnath Sen · 2021 · Medical Hypotheses
36. Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in subjects with COVID-19
    Georgia Colleluori, Laura Graciotti, Mauro Pesaresi, Angelica Di Vincenzo, Jessica Perugini, Eleonora Di Mercurio, Sara Caucci, Patrizia Bagnarelli, Cristina M. Zingaretti, Enzo Nisoli et al. · 2022 · International Journal of Obesity
37. Cerebral microvascular endothelial glycocalyx damage, its implications on the blood–brain barrier and a possible contributor to cognitive impairment
    Patrice Stoddart, Simon C. Satchell, Raina Devi Ramnath · 2022 · Brain Research
38. Pnictogen-Centered Cascade Exchangers for Thiol-Mediated Uptake: As(III)-, Sb(III)-, and Bi(III)-Expanded Cyclic Disulfides as Inhibitors of Cytosolic Delivery and Viral Entry
    Bumhee Lim, Takehiro Kato, Céline Besnard, Amalia I. Poblador‐Bahamonde, Naomi Sakai, Stefan Matile · 2022 · JACS Au
39. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase
    Pinja Kettunen, Angelina Lesnikova, Noora Räsänen, Ravi Ojha, Leena Palmunen, Markku Laakso, Šárka Lehtonen, Johanna Kuusisto, Olli P. H. Pietiläinen, Saber H. Saber et al. · 2023 · Journal of Virology
40. SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
    Romal Stewart, Kexin Yan, Sevannah A. Ellis, Cameron R. Bishop, Troy D. Dumenil, Bing Tang, Wilson Nguyen, Thibaut Larcher, Rhys H. Parry, Julian D. J. Sng et al. · 2023 · Frontiers in Microbiology
41. Current progress and challenges in the design and development of a successful COVID-19 vaccine
    Ting-Ting Li, Tian-Ying Zhang, Ying Gu, Shaowei Li, N. Xia · 2021 · Fundamental Research
42. Elucidating of oxidative distress in COVID-19 and methods of its prevention
    Anna‐Maria Barciszewska · 2021 · Chemico-Biological Interactions
43. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic
    Xue Li, Liying Zhang, Si Emma Chen, Weilong Ji, Chang Li, Linzhu Ren · 2021 · Infection Genetics and Evolution
44. Dysautonomia and Implications for Anosmia in Long COVID-19 Disease
    Alexandre Vallée · 2021 · Journal of Clinical Medicine
45. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
    Periklis Katopodis, Harpal Singh Randeva, Demetrios A. Spandidos, Sayeh Saravi, Ioannis Kyrou, Emmanouíl Karteris · 2021 · International Journal of Molecular Medicine
46. The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2
    Vi Nguyen, Yuping Zhang, Chao Gao, Xiaoling Cao, Yan Tian, Wayne E. Carver, Hippokratis Kiaris, Taixing Cui, Wenbin Tan · 2022 · Cells
47. Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic
    Luca Steardo, Luca Steardo, Caterina Scuderi · 2022 · Neurochemical Research
48. The multifaceted roles of NLRP3-modulating proteins in virus infection
    James Harris, Natalie A. Borg · 2022 · Frontiers in Immunology
49. Innate immune recognition against SARS-CoV-2
    Taisho Yamada, Akinori Takaoka · 2023 · Inflammation and Regeneration
50. SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
    Lu Miao, Chunyu Yan, Yingzhu Chen, Wei Zhou, Xuelian Zhou, Qinglong Qiao, Zhaochao Xu · 2023 · Cell chemical biology
51. Out of the ESCPE room: Emerging roles of endosomal SNX‐BARs in receptor transport and host–pathogen interaction
    Boris Simonetti, James L. Daly, Peter J. Cullen · 2023 · Traffic
52. HSPA5 Promotes Attachment and Internalization of Porcine Epidemic Diarrhea Virus through Interaction with the Spike Protein and the Endo-/Lysosomal Pathway
    Chuanjie Zhou, Yunchao Liu, Qiang Wei, Yumei Chen, Suzhen Yang, Anchun Cheng, Gaiping Zhang · 2023 · Journal of Virology
53. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
54. Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
    Yilin Kang, Jussi Hepojoki, Rocio Sartori-Maldonado, Takayuki Mito, Mügen Terzioglu, Tuula Manninen, Ravi Kant, Sachin Kumar Singh, Alaa Othman, Rohit Verma et al. · 2024 · Nature
55. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
    Marianne Riou, Florence Coste, Alain Meyer, Irina Enache, Samy Talha, Anne Charloux, Cyril Reboul, Bernard Gény · 2024 · International Journal of Molecular Sciences
56. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Georgios Chamilos, Michail S. Lionakis, Dimitrios P. Kontoyiannis · 2020 · Clinical Infectious Diseases
57. Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer’s Disease Patients Group Brain Using Genome-Wide Association Study Approach
    Key‐Hwan Lim, Sumin Yang, Sung-Hyun Kim, Jae‐Yeol Joo · 2021 · Frontiers in Genetics
58. SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
    Andrew R. McGill, Roukiah Khalil, Rinku Dutta, Ryan J. Green, Mark Howell, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Infectious Disease Reports
59. Role of SARS-CoV-2 and ACE2 variations in COVID-19
    Priya Antony, Ranjit Vijayan · 2021 · Biomedical Journal
60. Dysregulation of COVID-19 related gene expression in the COPD lung
    the MICA II Studygroup, Alastair Watson, Lisa Öberg, B. Angermann, Cosma Mirella Spalluto, Michael H. Hühn, Hannah Burke, Doriana Cellura, Anna T. Freeman, Daniel Muthas et al. · 2021 · Respiratory Research
61. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms
    Chuan Xu, Annie Wang, Ke Geng, W. Honnen, Xue-Ning Wang, N. Bruiners, Sukhwinder Singh, F. Ferrara, S. D'Angelo, A. Bradbury et al. · 2021 · Viruses
62. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions
    Marcel Renn, Eva Bartok, Thomas Zillinger, Gunther Hartmann, Rayk Behrendt · 2021 · Pharmacology & Therapeutics
63. Studying SARS-CoV-2 with Fluorescence Microscopy
    Lidia V. Putlyaeva, Konstantin A. Lukyanov · 2021 · International Journal of Molecular Sciences
64. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms
    Danielly S. Campos-Ferreira, Valéria Visani, C. Córdula, G.A. Nascimento, Lílian Maria Lapa Montenegro, Haiana Charifker Schindler, Isabella Macário Ferro Cavalcanti · 2021 · Biochemical Engineering Journal
65. Covid-19 interface with drug misuse and substance use disorders
    Irma E. Cisneros, Kathryn A. Cunningham · 2021 · Neuropharmacology
66. SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response
    Sneha Singh, Gustavo Garcia, Ruchi Shah, Andrei A. Kramerov, Robert E. Wright, Tanya Magazinnik Spektor, Alexander V. Ljubimov, Vaithilingaraja Arumugaswami, Ashok Kumar · 2021 · The Ocular Surface
67. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine
    Lorella Paparo, Maria Antonia Maglio, Maddalena Cortese, Cristina Bruno, Mario Capasso, Erika Punzo, Veronica Ferrucci, Vito Alessandro Lasorsa, Maurizio Viscardi, Giovanna Fusco et al. · 2022 · Molecules
68. SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression
    Anna Julie de Mello, Morgana Moretti, Ana Lúcia S. Rodrigues · 2022 · World Journal of Psychiatry
69. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
    Malik Johid Reza, Arpan Acharya, Sean N. Avedissian, Siddappa N. Byrareddy, Courtney Vail Fletcher, Anthony T. Podany, Shetty Ravi Dyavar · 2023 · International Journal of Molecular Sciences
70. An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
    2022
71. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations
    Francisco José Barrantes · 2021 · Brain Behavior & Immunity - Health
72. Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro
    Mei Hashizume, Gabriel González, Chikako Ono, Ayako Takashima, Masaharu Iwasaki · 2021 · Viruses
73. Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system
    Nengzhuang Wang, Lina Qin, Long Ma, Hongli Yan · 2021 · Stem Cell Research
74. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
    Stéphane Derruau, Jérôme Bouchet, Ali Nassif, Alexandre Baudet, Kazutoyo Yasukawa, Sandrine Lorimier, Isabelle Prêcheur, Agnès Bloch‐Zupan, B. Pellat, Hélène Chardin et al. · 2021 · Journal of Clinical Medicine
75. Overview of COVID-19 and neurological complications
    Nasrin Hosseini, Shabnam Nadjafi, Behnaz Ashtari · 2021 · Reviews in the Neurosciences
76. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
    Elham Bidram, Yasaman Esmaeili, Abbas Amini, Rossella Sartorius, Franklin R. Tay, Laleh Shariati, Pooyan Makvandi · 2021 · ACS Biomaterials Science & Engineering
77. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
    Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, Kamini Jakhar, Sudipta Sonar, Shailendra Mani, Sankar Bhattacharyya et al. · 2021 · Frontiers in Immunology
78. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
    Alex Sampson, Jonathan Luke Heeney, Diego M. Cantoni, Matteo Ferrari, Maria Suau Sans, Charlotte L. George, Cecilia Di Genova, Martin Mayora Neto, Sebastian Einhauser, Benedikt Asbach et al. · 2021 · Viruses
79. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
    Rey Arturo T. Fernandez, Mark Tristan J. Quimque, Kin Israel Notarte, Joe Anthony Manzano, Delfin Yñigo H. Pilapil, Von Novi de Leon, John Jeric P. San Jose, Omar A. Villalobos, Nisha Harur Muralidharan, M. Michael Gromiha et al. · 2021 · Journal of Biomolecular Structure and Dynamics
80. Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
    Anja Kolarič, Marko Jukič, Urban Bren · 2022 · Pharmaceuticals
81. Neuropilin‐1‐Mediated SARS‐CoV‐2 Infection in Bone Marrow‐Derived Macrophages Inhibits Osteoclast Differentiation
    Junjie Gao, Hong Mei, Jing Sun, Hao Li, Yuege Huang, Yanhong Tang, Linwei Duan, Delin Liu, Yidan Pang, Qiyang Wang et al. · 2022 · Advanced Biology
82. Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung
    Xinxin Wang, Jie Denny Luo, Zhiyuan Wen, Lei Shuai, Chong Wang, Gongxun Zhong, Xijun He, Huizhen Cao, Renqiang Liu, Jinying Ge et al. · 2022 · PLoS Pathogens
83. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
    Thomas A. Premeaux, Stephen T. Yeung, Zaheer Bukhari, Scott A. Bowler, Oral Alpan, Raavi Gupta, Lishomwa C. Ndhlovu · 2022 · Frontiers in Immunology
84. Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus
    Hideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Taka‐aki Matsuoka, Kohei Kaku · 2022 · Biomedicines
85. Pathogenesis of Olfactory Disorders in COVID-19
    Laura Ziuzia-Januszewska, Marcin Januszewski · 2022 · Brain Sciences
86. Rapidly evolving viral motifs mostly target biophysically constrained binding pockets of host proteins
    Gal Shuler, Tzachi Hagai · 2022 · Cell Reports
87. The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes
    María Mercado-Gómez, Endika Prieto‐Fernández, Naroa Goikoetxea‐Usandizaga, Laura Vila-Vecilla, Mikel Azkargorta, Miren Bravo, Marina Serrano‐Maciá, Leire Egia‐Mendikute, Rubén Rodríguez Agudo, Sofía Lachiondo‐Ortega et al. · 2022 · Communications Biology
88. Photochemical Identification of Auxiliary Severe Acute Respiratory Syndrome Coronavirus 2 Host Entry Factors Using μMap
    Saori Suzuki, Jacob B. Geri, Steve D. Knutson, Harris Bell‐Temin, Tomokazu Tamura, David F. Fernández, Gabrielle H. Lovett, Nicholas A. Till, Brigitte L. Heller, Jinchao Guo et al. · 2022 · Journal of the American Chemical Society
89. SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions
    Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval · 2022 · Cell Biology International
90. Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions
    Shaun M. Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg · 2022 · Science Advances
91. The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation
    Chenxu Guo, Shang Jui Tsai, Yiwei Ai, Maggie Li, Andrew S Pekosz, Andrea Cox, Nadia A. Atai, Stephen J. Gould · 2022 · Science Advances
92. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
    Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, Marco Thomas · 2023 · Viruses
93. Light Sheet Microscopy-Assisted 3D Analysis of SARS-CoV-2 Infection in the Respiratory Tract of the Ferret Model
    Luca M. Zaeck, David Scheibner, Julia Sehl‐Ewert, Martin Müller, Donata Hoffmann, Martin Beer, Elsayed M. Abdelwhab, Thomas C. Mettenleiter, Angele Breithaupt, Stefan Finke · 2021 · Viruses
94. Nasal expression of SARS-CoV-2 entry receptors in newborns
    Santtu Heinonen, Otto Helve, STURE M. ANDERSSON, Cecilia Janér, Liina Süvari, Anu K. Kaskinen · 2021 · Archives of Disease in Childhood Fetal & Neonatal
95. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Pankaj Kumar Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis Kumar Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Frontiers in Immunology
96. SARS-CoV-2 cell entry and targeted antiviral development
    Zi-Nuo Chen, R. Du, Jazmin M. Galván Achi, Li-Jun Rong, Q. Cui · 2021 · Acta Pharmaceutica Sinica B
97. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
    Yinfang Wang, Ying‐Zhe Fan, Yitong Huang, Tao Du, Zongjun Liu, Dekui Huang, Ying Wang, Nanping Wang, Peng Zhang · 2021 · Cellular Signalling
98. Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies
    Claudia Pommerenke, Ulfert Rand, Cord C. Uphoff, Stefan Nagel, Margarete Zaborski, Vivien Hauer, Maren Kaufmann, Corinna Meyer, Sabine A. Denkmann, Peggy Riese et al. · 2021 · PLoS ONE
99. Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers
    Tsuguhisa Nakayama, Ivan T. Lee, Sizun Jiang, Matthias Sebastian Matter, Carol H. Yan, Jonathan B. Overdevest, Chien-Ting Wu, Yury Goltsev, Liang‐Chun Shih, Steven Chun‐Kang Liao et al. · 2021 · Cell Reports Medicine
100. Counting the neurological cost of COVID-19
     Abdul Mannan Baig · 2021 · Nature Reviews Neurology